TMS, ketamine, esketamine, ECT – interventional psychiatry is gaining clinical momentum, but the investment landscape remains complex. This panel examines the reimbursement realities, scalability challenges, and market opportunities that will determine whether interventional psychiatry becomes behavioral health's next major asset class.
Thank you for your interest in Sponsoring Behavioral Health Business Events. Someone from our sales team will be in contact with you soon.
X